Type I and II diabetes ultimately result in the loss of insulin-producing beta cells in the pancreas. Current attractive therapeutic strategies aim at replacing these cells by using stem or progenitor cells differentiated in vitro. Using a transgenic approach, Collombat et al. now reveal that ectopic expression of the Pax4 gene in diverse endocrine cell subtypes, including alpha cells, induces a continuous conversion of progenitor cells into functional beta cells. These transdifferentiated cells are functional and can reverse the consequences of chemically induced type I diabetes in vivo. Thus, making new beta cells from preexisting latent stem/progenitor cells and alpha cells may be a new avenue for therapy.
The nuclear receptors known as PPARs modulate metabolic and inflammatory pathways by responding to nutritional signals through ligand activation of transcription. They are the targets of drugs in use and in development for disease therapy. No authentic endogenous PPAR ligand (the molecule that occupies the nuclear receptor binding site in vivo while the receptor is actively driving transcription) has been identified. Chakravarthy et al. now provide evidence that endogenous lipid synthesis generates a discrete phosphatidylcholine species that serves as an endogenous ligand for PPARa.
Telomerase: Length Doesn't Matter PAGE 463
A central question in telomere biology concerns how telomerase maintains telomere length. Many studies have suggested that telomerase is preferentially recruited to the shortest telomeres. However, Zhou et al. now show that under telomere length-maintenance conditions in human cancer cells, telomerase extends the vast majority of chromosome ends irrespective of length. The authors also find that extension of the chromosome end by telomerase after telomere replication is both mechanistically and temporally distinct from filling-in of the extended single-stranded overhang. These results reveal new steps in human telomere maintenance and may have important implications for both cancer and aging.
Transcription, One Cycle at a Time PAGE 489 Eukaryotic transcription is a dynamic process relying on a large number of proteins. By measuring the cycling expression of the pyruvate dehydrogenase kinase 4 gene in human cells, Degenhardt et al. now construct a detailed stochastic model for single-gene transcription at the molecular level using realistic kinetics for diffusion and protein complex dynamics. The model can predict the precise timing of single-gene activity that leads to transcriptional cycling on the cell population level when taking into account the sequential and irreversible multistep nature of transcriptional initiation. This systems biology approach proposes that the cyclic nature of population gene expression is primarily based on the intrinsic periodicity of the transcription process itself.
Chromatin Tailors a Spindle to Fit PAGE 502
The mitotic spindle is a bipolar structure made of microtubules and is required for chromosome segregation prior to cell division. Using microfabricated chromatin-coated beads to form patterns of chromatin that differ in size and shape, Dinarina et al. now systematically characterize the dynamics in spindle assembly, shape, and polarity as a function of chromatin mass. Their results demonstrate that chromatin size and shape defines spindle shape and orientation.
Controlling Chloride Cotransporters PAGE 525
Modulation of the intracellular chloride concentration via K-Cl cotransporters plays a fundamental role in diverse processes, including the regulation of cell volume and neuronal excitation. Rinehart et al. now apply cutting-edge techniques in phosphoproteomics to identify two conserved phosphorylation sites that control K-Cl cotransporter activity. These sites are rapidly dephosphorylated in response to osmotic stress, and their mutation to alanines results in constitutive transporter activity. These sites also show regulated phosphorylation in red blood cells and neurons. The authors go on to identify candidate controlling kinases, providing new insights into the regulation of cell volume and neuronal function.
Second SH2 Site Specifies Signaling Specificity PAGE 514
Receptor tyrosine kinases (RTKs) control many important cellular processes by activating intracellular signaling pathways through the recruitment and phosphorylation of signaling proteins containing SH2 domains. These domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. Bae et al. now provide evidence that in vivo signaling selectivity for the interaction between the FGFR1 RTK and phospholipase Cg is determined by additional phosphorylationindependent interactions between the RTK kinase domain and a secondary SH2 binding site. The findings reveal a mechanism for ensuring signaling specificity in the midst of numerous possible SH2-RTK cellular interactions.
Cargo Is a Myosin Matchmaker PAGE 537
Myosin VI is unique among uncoventional myosins in its ability to move to the minus end of actin filaments. Although mobile as monomers, the processive walking of unconventional myosins on filaments requires dimerization of the motors. Yu et al. now show that myosin VI uses an unanticipated mechanism for dimerization. The authors apply several techniques to solve the structures of the myosin VI tail cargo binding domain in its free and cargo-bound forms. The structures reveal that myosin VI undergoes a cargo-mediated monomer to dimer conversion, providing a new and potentially broadly utilized mechanism in the regulation of myosin motor processitivity.
The ER Gets Hooked Up, Atlast PAGE 549
Cellular organelles have characteristic shapes. For example, the endoplasmic reticulum (ER), which is responsible for the synthesis of lipids or secreted proteins (such as insulin), consists of tubules and sheets. Previous work had identified proteins that shape the tubules. Hu et al. now demonstrates that additional proteins are required to interconnect the tubules to form a polygonal network. These proteins-atlastins in mammals and Sey1 p in yeast-are membrane-bound GTPases that belong to the dynamin family. Mutations in atlastin-1 cause a common form of hereditary spastic paraplegia, suggesting that defects in ER morphology may underlie the disease.
IRE1a at the Crossroads of Splicing and Apoptosis

PAGE 562
Endoplasmic reticulum (ER) stress triggers the unfolded protein response (UPR), an adaptive pathway that increases the ER's folding capacity. If homeostasis is not restored, the UPR induces apoptosis. Han et al. now identify the ER transmembrane kinase/endoribonuclease (RNase) IRE1a as a key component of this apoptotic switch. Besides splicing XBP1 mRNA to promote adaptation to ER stress, IRE1a activated by autophosphorylation also degrades many ER-localized mRNAs, thereby promoting apoptosis. Using chemical genetics, the authors show that kinase inhibitors blocking IRE1a autophosphorylation can activate the RNase activity of IRE1a via an alternate mode that enforces XBP1 splicing, averts mRNA decay and apoptosis, and may have important therapeutic ramifications.
RNA Polymerase Battles Foreign DNA in the Cytoplasm
PAGE 576
Delivery of double-stranded DNA into a cell's cytoplasm can trigger the potent induction of type I interferons that are important for host immune defense. This response serves the cell well in combating microbial infections but can also lead to autoimmune diseases. Chiu et al. now identify cytoplasmic RNA polymerase III as a DNA sensor that triggers interferon production. The polymerase converts cytoplasmic DNA into 5 0 -triphosphorylated RNA, which binds to and activates RIG-I to induce type I interferons. These findings provide the identity of the sensor and resolve the long-standing mystery of why cells maintain a cytoplasmic pool of RNA polymerase III.
MicroRNAs on Duty in Normal and Cancer Stem Cells PAGE 592
Cancer stem cells provide certain cancer types with high tumorigenic capacity. Shimono et al. now report that in cancer stem cells and in normal stem cells, three miRNA clusters are coordinately downregulated. One of the downregulated miRNAs, miR-200c, controls the selfrenewal gene BMI1 and strongly suppresses the capacity for clonal expansion in normal and malignant breast stem cells. These findings provide evidence that cancer stem cells and normal stem cells share molecular mechanisms that regulate growth and differentiation.
